Table 2 — Immune Modulators With No Completed Studies In Type 2 Diabetic Patients1

• Azathioprine


Continue Reading

• Cyclosporine

• Cyclophosphamide

• Leflunomide

• Minocycline

• Mycophenolate mofetil

• Abatacept

• Alefacept

• Rituximab

• Tocilizumab